671 CLINICAL FEATURES OF NON ALCOHOLIC STEATOHEPATITIS (NASH)-RELATED HEPATOCELLULAR CARCINOMA (HCC) IN ITALY: A MULTICENTER PROSPECTIVE SURVEY
Angelo Rossini(Centro Universitário Barão de Mauá), Mauro Borzio(Ospedale Papa Giovanni XXIII), Fabio Fornari(Azienda Unità Sanitaria Locale Piacenza), Michela Di Fonzo(Chase Farm Hospital), E. Dionigi, Rodolfo Sacco, G. Spinzi(Ospedale Valduce), Susanna Vicari(Presidenza Del Consiglio Dei Ministri), G. Francica(Santa Maria Nuova Hospital), Andrea Salmi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), M. Salvagnini(Ospedale San Bortolo), Fabio Farinati(University of Padua), Ilario de Sio(University of Campania "Luigi Vanvitelli"), Giuseppe Fabio Parisi(University of Catania)
Cited by 0
Related Papers
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
|Hepatology|2020|302
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
|The Lancet Oncology|2023|184
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133
Anticoagulant treatment in COVID-19: a narrative review
|Journal of Thrombosis and Thrombolysis|2020|111